NASDAQ:GTBP
GT Biopharma, Inc.
- Stock
Last Close
2.72
26/07 20:00
Market Cap
6.06M
Beta: 0.86
Volume Today
2.40K
Avg: 131.26K
PE Ratio
−15.25
PFCF: −19.13
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 50.50K - | 21K 58.42% | ||||||||||
average payables | 909K - | 676K 25.63% | 652.50K 3.48% | 1.50M 129.35% | 2.32M 55.23% | 2.15M 7.28% | 1.85M 14.07% | 2.09M 12.99% | 5.22M 149.39% | 5.66M 8.60% | 3.73M 34.08% | |
average receivables | 20K - | 20K 0% | ||||||||||
book value per share | -13.77K - | -63.37K 360.35% | -131.20K 107.03% | -3.91K 97.02% | 255.33 106.52% | 3.90 98.47% | -5.65 244.81% | -6.67 18.03% | 0.78 111.66% | 0.37 52.68% | 0.01 98.49% | |
capex per share | -12.93 - | -2.13 83.55% | -0.00 - | -0.01 200.40% | ||||||||
capex to depreciation | -0.27 - | -0.50 83.33% | -2 - | -5.14 157.14% | ||||||||
capex to operating cash flow | 0.00 - | 0.00 93.74% | 0.00 - | 0.00 357.71% | ||||||||
capex to revenue | -0.10 - | -0.04 62.35% | ||||||||||
cash per share | 95.77 - | 1.84K 1,824.09% | 100 94.57% | 3.97 96.03% | 0.58 85.28% | 0.02 96.52% | 0.01 59.26% | 1.21 14,504.29% | 1.14 5.97% | 0.52 54.39% | 0.01 98.00% | |
days of inventory on hand | 67.83 - | |||||||||||
days payables outstanding | 1.52K - | 2.64K 73.78% | ||||||||||
days sales outstanding | 39.67 - | |||||||||||
debt to assets | 17.61 - | 3.78 78.51% | 180.50 4,671.78% | 496.52 175.08% | 0.00 100.00% | 0.43 348,934.81% | 33.73 7,830.09% | 4.65 86.21% | 0.00 99.98% | 0.01 978.88% | 0.00 60.46% | |
debt to equity | -0.42 - | -0.11 72.72% | -0.16 38.37% | -0.66 318.72% | 0.00 100.02% | 0.94 760,594.82% | -0.70 174.54% | -0.90 28.95% | 0.00 100.16% | 0.01 948.05% | 0.01 47.68% | |
dividend yield | ||||||||||||
earnings yield | -10.59 - | -480.29 4,436.86% | -660.62 37.55% | 41.65 106.30% | -1.92 104.61% | -7.94 313.46% | -8.73 9.97% | -1.00 88.54% | -0.68 31.65% | -0.73 6.24% | -0.00 99.90% | |
enterprise value | 2.59M - | 2.55M 1.52% | 9.75M 281.90% | 12.90M 32.30% | 74.08M 474.29% | 43.40M 41.41% | 18.00M 58.52% | 52.65M 192.50% | 76.94M 46.12% | 22.74M 70.45% | 10.31B 45,239.98% | |
enterprise value over ebitda | -1.17 - | -1.08 8.07% | -1.09 1.58% | -0.28 74.52% | -0.54 94.95% | -2.01 271.13% | -1.57 21.96% | -2.72 73.02% | -1.34 50.78% | -1.08 18.98% | -759.35 69,917.14% | |
ev to operating cash flow | -5.86 - | -1.46 75.11% | -2.09 43.43% | -6.68 219.24% | -13.64 104.12% | -4.06 70.20% | -4.92 21.03% | -7.25 47.38% | -4.93 32.01% | -1.49 69.69% | -1.16K 77,841.54% | |
ev to sales | 7.04 - | 41.85 494.11% | 361.09 762.81% | |||||||||
free cash flow per share | -984.41 - | -3.78K 284.22% | -9.91K 162.02% | -402.84 95.94% | -5.51 98.63% | -3.62 34.20% | -1.08 70.18% | -1.66 53.22% | -0.55 66.53% | -0.48 13.85% | -0.01 98.62% | |
free cash flow yield | -9.34 - | -35.89 284.22% | -94.03 162.02% | -3.82 95.94% | -0.07 98.09% | -0.33 350.50% | -0.78 138.75% | -0.23 70.67% | -0.18 20.88% | -0.54 196.56% | -0.00 99.84% | |
graham net net | -14.22K - | -63.81K 348.57% | -131.58K 106.21% | -3.95K 97.00% | -2.13 99.95% | -4.73 121.71% | -5.81 22.98% | -6.79 16.90% | 0.77 111.35% | 0.36 53.20% | 0.01 98.49% | |
graham number | 18.59K - | 268.67K 1,345.18% | 453.38K 68.75% | 19.66K 95.66% | 913.38 95.36% | 87.78 90.39% | 39.14 55.40% | 32.90 15.95% | 6.04 81.64% | 2.31 61.79% | 0.03 98.85% | |
income quality | 0.88 - | 0.07 91.56% | 0.14 91.11% | -0.09 164.48% | 0.04 141.31% | 0.04 8.67% | 0.09 129.83% | 0.26 171.07% | 0.27 4.82% | 0.73 170.86% | 1.17 59.91% | |
intangibles to total assets | 0.15 - | 0 100% | 0 | 0 | 1.00 Infinity% | 0.99 0.31% | 0 100% | 0 | 0 | 0 | 0 | |
interest coverage | 0.66 - | -0.47 170.22% | -0.52 12.52% | 1.43 372.95% | 15.76 1,002.08% | -27.43 274.04% | -7.55 72.49% | -2.04 73.00% | -80.10 3,831.80% | -2.66K 3,217.08% | -63.74 97.60% | |
interest debt per share | 3.10K - | 18.33K 491.24% | 56.99K 210.92% | 1.22K 97.85% | -8.69 100.71% | 6.74 177.58% | 4.57 32.14% | 6.76 47.83% | 0.03 99.61% | 0.01 78.53% | 0.00 96.48% | |
inventory turnover | 5.38 - | |||||||||||
invested capital | -0.42 - | -0.11 72.72% | -0.16 38.37% | -0.66 318.72% | 0.00 100.02% | 0.94 760,594.82% | -0.70 174.54% | -0.90 28.95% | 0.00 100.16% | 0.01 948.05% | 0.01 47.68% | |
market cap | 47.32K - | 48.91K 3.34% | 49.54K 1.29% | 504.97K 919.36% | 74.62M 14,677.59% | 32.66M 56.24% | 4.67M 85.69% | 31.62M 576.78% | 85.87M 171.61% | 28.24M 67.12% | 10.31B 36,414.89% | |
net current asset value | -6.36M - | -29.58M 365.39% | -61.84M 109.06% | -18.93M 69.39% | -2.10M 88.89% | -13.94M 562.82% | -19.43M 39.41% | -29.43M 51.47% | 21.91M 174.44% | 11.56M 47.24% | 7.42M 35.79% | |
net debt to ebitda | -1.15 - | -1.05 8.16% | -1.09 3.04% | -0.27 75.39% | 0.00 101.49% | -0.50 12,588.01% | -1.16 133.42% | -1.09 6.65% | 0.16 114.31% | 0.26 68.66% | 0.08 71.32% | |
net income per share | -1.12K - | -50.62K 4,436.86% | -69.63K 37.55% | 4.39K 106.30% | -145.22 103.31% | -87.70 39.61% | -12.04 86.27% | -7.21 40.14% | -2.08 71.09% | -0.64 69.14% | -0.01 99.12% | |
operating cash flow per share | -984.41 - | -3.77K 282.91% | -9.91K 162.87% | -402.84 95.93% | -5.50 98.63% | -3.61 34.37% | -1.08 70.08% | -1.66 53.22% | -0.55 66.53% | -0.48 13.85% | -0.01 98.62% | |
payables turnover | 0.24 - | 0.14 42.46% | ||||||||||
receivables turnover | 9.20 - | |||||||||||
research and ddevelopement to revenue | 37.04 - | |||||||||||
return on tangible assets | -4.01 - | -26.45 559.97% | -606.04 2,191.12% | 841.32 238.82% | -242.38 128.81% | -1.89K 680.54% | -102.97 94.56% | -5.58 94.58% | -1.82 67.33% | -1.23 32.85% | -0.54 56.05% | |
revenue per share | 819.60 - | 131.47 83.96% | 57.45 56.30% | |||||||||
roe | 0.08 - | 0.80 885.52% | 0.53 33.56% | -1.12 311.31% | -0.57 49.28% | -22.46 3,849.24% | 2.13 109.48% | 1.08 49.28% | -2.68 347.95% | -1.75 34.77% | -1.02 41.84% | |
roic | 0.11 - | 0.11 5.36% | 0.26 133.15% | 3.61 1,282.55% | -0.57 115.69% | -1.32 133.56% | 2.99 325.86% | 2.58 13.77% | -2.65 202.82% | -1.73 34.87% | -1.79 3.53% | |
sales general and administrative to revenue | 2.54 - | |||||||||||
shareholders equity per share | -13.77K - | -63.37K 360.35% | -131.20K 107.03% | -3.91K 97.02% | 255.33 106.52% | 3.90 98.47% | -5.65 244.81% | -6.67 18.03% | 0.78 111.66% | 0.37 52.68% | 0.01 98.49% | |
stock based compensation to revenue | 0.48 - | 43.11 8,914.90% | 139.30 223.08% | |||||||||
tangible asset value | -6.36M - | -29.57M 365.29% | -61.83M 109.08% | -18.92M 69.40% | -2.09M 88.97% | -13.89M 565.33% | -19.31M 39.00% | -29.43M 52.42% | 21.91M 174.44% | 11.73M 46.44% | 7.48M 36.29% | |
tangible book value per share | -14.16K - | -63.74K 350.25% | -131.56K 106.41% | -3.95K 97.00% | -2.12 99.95% | -4.70 122.07% | -5.70 21.34% | -6.71 17.67% | 0.78 111.59% | 0.37 52.68% | 0.01 98.49% | |
working capital | -6.26M - | -28.95M 362.47% | -61.13M 111.17% | -18.93M 69.03% | -2.10M 88.89% | -13.94M 562.82% | -19.43M 39.41% | -29.43M 51.47% | 21.91M 174.44% | 11.62M 46.95% | 7.42M 36.14% |
All numbers in USD (except ratios and percentages)